Despite rising costs in its health insurance plans, Elevance Health reported more than $2 billion in first quarter net income ...

Health insurer Elevance Health said on Tuesday its first-quarter profit came above Street expectations, matching the ...

Fintel reports that on April 15, 2025, Baird downgraded their outlook for Elevance Health (NYSE:ELV) from Outperform to ...

Fintel reports that on April 9, 2025, Guggenheim initiated coverage of Elevance Health (NYSE:ELV) with a Buy recommendation.

Elevance Health lowered its profit guidance but held tight on its adjusted earnings target for the year after higher yields and more members boosted first-quarter revenue.

The health insurer posted revenue of $48.89 billion in the period. Its adjusted revenue was $48.77 billion, also topping Street forecasts. Seventeen analysts surveyed by Zacks expected $46.03 billion.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. It operates in four segments: Health Benefits, CarelonRx, Carelon Services ...

A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024 and earned $45 billion in revenue in the quarter. For full-year 2024, Elevance reported $175.2 billion in revenue, an ...

Baird notes Elevance Health (ELV) pre-announced a Q1 earnings beat with adjusted EPS of $11.97 vs. $11.62 implied guide, vs. $11.32 street, vs. its $11.63. The company cites medical costs ...

Elevance Health Stock Up 0.3 % Elevance Health stock opened at $441.02 on Tuesday. The stock has a 50 day moving average of $413.71 and a two-hundred day moving average of $411.99. Elevance Health ...